Skip Navigation


Rheumatology Advance Access originally published online on August 18, 2008
Rheumatology 2008 47(10):1591; doi:10.1093/rheumatology/ken327
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
47/10/1591-a    most recent
ken327v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chakravarty, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chakravarty, K.
Related Collections
Right arrow Rehabilitation
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists: reply

K. Chakravarty1

1Rheumatology Department, Queen's; Hospital, Essex, UK

Correspondence to: K. Chakravarty, Rheumatology Department, Queen's Hospital, Rom Valley Way, Romford, Essex RM7 OBE, UK. E-mail: kuntal@talk21.com

The first 10% of the full text of this article appears below.

Sir, We would like to thank Dr Bhalla and his colleague [1] for raising an . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?